NDA 200477 describes RISEDRONATE SODIUM, which is a drug marketed by
Impax Labs Inc,
Sun Pharm,
Teva Pharms Usa,
Zydus Pharms,
Apotex,
Aurobindo Pharma,
Aurobindo Pharma Ltd,
Hangzhou Binjiang,
Macleods Pharms Ltd,
Mylan, and
Orbion Pharms, and is included in fourteen NDAs. It is available from
eleven suppliers. Additional details are available on the
RISEDRONATE SODIUM profile page.
The generic ingredient in RISEDRONATE SODIUM is
risedronate sodium. There are nineteen
drug master file entries for this compound. Thirteen
suppliers are listed for this compound. Additional details are available on the
risedronate sodium profile page.